Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fortress Biotech Inc (NQ: FBIO )

3.850 USD -0.020 (-0.52%)
Streaming Delayed Price Updated: 8:42 AM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Fortress Biotech Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
21 22 Next >
Mustang Bio to Present at the Phacilitate Leaders World & World Stem Cell Summit 2020
From GlobeNewswire News Releases
The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags REPL ATRC Benzinga
From Benzinga
76 Biggest Movers From Yesterday
Gainers The McClatchy Company (NYSE: MNI) shares climbed 241.8% to close at $1.50 on Thursday after the company announced it ... 
Tags RWLK OMI MBIO
From Benzinga
42 Stocks Moving In Thursday's Mid-Day Session
Gainers The McClatchy Company (NYSE: MNI) shares jumped 435.6% to $2.35 after the company announced it entered into a standstill ... 
Tags TCON PTE NK
From Benzinga
How The Pieces Add Up: IWC Targets $123
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Fortress Biotech Announces Rare Pediatric Disease Designation for CUTX-101 for the Treatment of Menkes Disease
Cyprium Therapeutics, a Fortress partner company, on track to begin submitting rolling New Drug Application for CUTX-101 to the FDA in the second half of 2020 
From GlobeNewswire News Releases
Checkpoint Therapeutics Announces Confirmation of Registration Path for Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
From GlobeNewswire News Releases
Journey Medical Corporation Recaps 2019 Growth
From GlobeNewswire News Releases
The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags ACOR Pre/Market Outlook EPZM
From Benzinga
The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech ... 
Tags MDCO Benzinga MDGS
From Benzinga
The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech ... 
Tags IBB SWTX SPPI
From Benzinga
Fortress Biotech Announces Exclusive Worldwide License Agreement With AstraZeneca and Cincinnati Children’s Hospital Medical Center to Develop a Novel Treatment for Select CNS Disorders
Baergic Bio, a Fortress partner company, enters into an agreement with AstraZeneca for AZD7325, a novel α2/3–subtype-selective GABA A positive allosteric modulator 
From GlobeNewswire News Releases
36 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers Helius Medical Tech, Inc. (NASDAQ: HSDT) stock increased by 88.1% to $0.79 during Thursday's pre-market session. The ... 
Tags Top Gainers Trading Ideas SNY
From Benzinga
64 Biggest Movers From Yesterday
Gainers Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) shares jumped 44.1% to close at $23.76 on Wednesday. Mirum Pharmaceuticals ... 
Tags APTO IGMS Market News
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) shares climbed 32.3% to $21.82. Mirum Pharmaceuticals shares climbed 111% on ... 
Tags TTC FDX JCS
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 18, 2019
Upgrades JP Morgan upgraded the stock for Alexandria Real Estate Equities Inc (NYSE: ARE) from Neutral to Overweight. For the ... 
Tags EPR DAL CCMP
From Benzinga
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
From GlobeNewswire News Releases
5 Stocks Moving On ASH Presentations
The American Society of Hematology's 61st annual meeting is underway in Orlando, Florida. The four-day meeting kicked off ... 
Tags Trading Ideas FATE BMY
From Benzinga
Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency
From GlobeNewswire News Releases
The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
Biotech stocks went back and forth but managed to end the week with a gain. As usual, some stocks swung wildly in reaction to catalysts, ... 
Tags APDN GMAB BMY
From Benzinga
Analysts Anticipate 26% Upside For The Holdings of IWC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Mustang Bio to Participate in the Evercore ISI 2nd Annual HealthCONx Conference
From GlobeNewswire News Releases
Fortress Biotech to Participate in December 2019 Investor Conferences
From GlobeNewswire News Releases
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Biotech stocks advanced in the holiday-shortened week, with upside driven mainly by the broader market strength. Reflecting the extreme ... 
Tags CNTG TELA ETNB
From Benzinga
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
From GlobeNewswire News Releases
Checkpoint Therapeutics Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Checkpoint Therapeutics Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Fortress Biotech Ranked in Top 10 of Deloitte’s 2019 Technology Fast 500™
From GlobeNewswire News Releases
Mustang Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
From GlobeNewswire News Releases
Fortress Biotech Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
From GlobeNewswire News Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.